NYL Investors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Hold
110,785
0.39% 26
2026
Q1
$1.2M Hold
110,785
0.45% 28
2025
Q4
$677K Hold
110,785
0.23% 29
2025
Q3
$574K Hold
110,785
0.19% 33
2025
Q2
$657K Hold
110,785
0.18% 34
2025
Q1
$911K Hold
110,785
0.06% 32
2024
Q4
$915K Hold
110,785
0.08% 32
2024
Q3
$848K Hold
110,785
0.05% 31
2024
Q2
$1.15M Hold
110,785
0.08% 31
2024
Q1
$1.32M Hold
110,785
0.05% 31
2023
Q4
$1.2M Hold
110,785
0.05% 30
2023
Q3
$1.53M Hold
110,785
0.06% 26
2023
Q2
$1.33M Hold
110,785
0.06% 28
2023
Q1
$1.3M Hold
110,785
0.08% 27
2022
Q4
$1.87M Hold
110,785
0.13% 26
2022
Q3
$1.29M Hold
110,785
0.15% 28
2022
Q2
$1.75M Hold
110,785
0.21% 26
2022
Q1
$1.72M Hold
110,785
0.24% 30
2021
Q4
$936K Buy
+110,785
New +$955K 0.16% 33

Other funds holding PTEN

NYL Investors's PTEN Position: Q2 2026 in Review

NYL Investors held its Patterson-UTI (PTEN) position steady in Q2 2026 at 110,785 shares worth $1.02M. The position accounts for 0.39% of the portfolio, ranked #26.

NYL Investors first reported a position in PTEN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.87M in Q4 2022. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • NYL Investors held 110,785 shares of Patterson-UTI worth $1.02M as of Q2 2026.
  • NYL Investors left its Patterson-UTI share count unchanged in Q2 2026.
  • Patterson-UTI made up 0.39% of NYL Investors's portfolio in Q2 2026, its #26 holding.
  • NYL Investors first reported a position in Patterson-UTI in Q4 2021 and has held it in 19 quarters since.
  • NYL Investors's Patterson-UTI position peaked at $1.87M in Q4 2022.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on NYL Investors's 13F filing for Q2 2026, filed 12 Aug 2026.